Jason E Farley1. 1. School of Nursing, Johns Hopkins University, Baltimore, Maryland 21287, USA. jfarley@son.jhmi.edu
Abstract
PURPOSE: This article reviews the evolving epidemiology of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and the appropriate outpatient management of CA-MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed. DATA SOURCES: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966-2006). CONCLUSIONS: The epidemiology of CA-MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high-risk populations and within families is urgently needed. IMPLICATIONS FOR PRACTICE: Nurse practitioners must remain informed of the epidemiology of common and emerging drug-resistant organisms in their patient populations.
PURPOSE: This article reviews the evolving epidemiology of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and the appropriate outpatient management of CA-MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed. DATA SOURCES: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966-2006). CONCLUSIONS: The epidemiology of CA-MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high-risk populations and within families is urgently needed. IMPLICATIONS FOR PRACTICE: Nurse practitioners must remain informed of the epidemiology of common and emerging drug-resistant organisms in their patient populations.
Authors: Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington Journal: Clin Infect Dis Date: 2003-10-17 Impact factor: 9.079
Authors: B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum Journal: JAMA Date: 1998-02-25 Impact factor: 56.272
Authors: B Shopsin; B Mathema; J Martinez; E Ha; M L Campo; A Fierman; K Krasinski; J Kornblum; P Alcabes; M Waddington; M Riehman; B N Kreiswirth Journal: J Infect Dis Date: 2000-07-06 Impact factor: 5.226
Authors: G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne Journal: Clin Infect Dis Date: 1999-11 Impact factor: 9.079
Authors: Cecilia P Johnston; Lisa Cooper; William Ruby; Karen C Carroll; Sara E Cosgrove; Trish M Perl Journal: Infect Control Hosp Epidemiol Date: 2006-08-31 Impact factor: 3.254
Authors: R R Muder; C Brennen; M M Wagener; R M Vickers; J D Rihs; G A Hancock; Y C Yee; J M Miller; V L Yu Journal: Ann Intern Med Date: 1991-01-15 Impact factor: 25.391
Authors: Dominique L Monnet; Fiona M MacKenzie; José Maria López-Lozano; Arielle Beyaert; Máximo Camacho; Rachel Wilson; David Stuart; Ian M Gould Journal: Emerg Infect Dis Date: 2004-08 Impact factor: 6.883
Authors: Mary E Stemper; Jennifer M Brady; Salah S Qutaishat; Gwen Borlaug; James Reed; Kurt D Reed; Sanjay K Shukla Journal: Emerg Infect Dis Date: 2006-09 Impact factor: 6.883
Authors: James D Thacker; Brian J Balin; Denah M Appelt; Sihem Sassi-Gaha; Mitali Purohit; Richard F Rest; Carol M Artlett Journal: Antimicrob Agents Chemother Date: 2012-01-30 Impact factor: 5.191
Authors: Andrea Leinberger-Jabari; Rhonda G Kost; Brianna D'Orazio; Rhonda Burgess; Chamanara Khalida; Amanda Tsang; Dennis Mitchell; Alexander Tomasz; Herminia de Lencastre; Maria Pardos de la Gandara; Teresa H Evering; Tameir Holder; Barry S Coller; Jonathan N Tobin Journal: Prog Community Health Partnersh Date: 2016
Authors: D M Wolk; M J Struelens; P Pancholi; T Davis; P Della-Latta; D Fuller; E Picton; R Dickenson; O Denis; D Johnson; K Chapin Journal: J Clin Microbiol Date: 2009-01-14 Impact factor: 5.948